Table 5 Urinary concentrations of phthalate metabolites and bisphenol A in polycystic ovary syndrome (PCOS) case-patients and controls
Agents | Geometric mean concentration (μg/L) | Creatinine-adjusted geometric mean concentration (μg/g creatinine) | |||
|---|---|---|---|---|---|
Phthalates | Phthalate metabolites measured | PCOS case-patients | PCOS control-patients | PCOS case-patients | PCOS control-patients |
Butylbenzyl phthalate (BBzP) | Monobenzyl phthalate (mBzP) | 4.7 | 9.0 | 7.5 | 11.7a |
Di-n-butyl phthalate (DBP) | Mono-n-butyl phthalate (mBP) | 15.3 | 24.8 | 17.7 | 23.2 |
Diethyl phthalate (DEP) | Monoethyl phthalate (mEP) | 103.7 | 138.3 | 181.1 | 195.8 |
Di-isodecyl phthalate (DiDP) | Mono(carboxynonyl) phthalate (mCNP) | 3.2 | 3.0 | 3.6 | 2.6 |
Di-isononyl phthalate (DiNP) | Mono(carboxyoctyl) phthalate (mCOP) | 6.7 | 9.0 | 7.8 | 8.4 |
Di-n-octyl phthalate (DOP) | Mono-3-carboxypropyl phthalate (mCPP) | 2.4 | 3.6 | 2.8 | 3.4 |
Di-2-ethylhexyl phthalate (DEHP) | Mono-2-ethyl-5-carboxypentyl phthalate (mECPP) | 41.5 | 43.2 | 47.9 | 40.4 |
Mono-2-ethyl-5-hydroxyhexyl phthalate (mEHHP) | 23.7 | 28.3 | 27.3 | 26.4 | |
Mono-2-ethylhexyl phthalate (mEHP) | 3.3 | 4.0 | 3.2 | 3.5 | |
Mono-2-ethyl-5-oxohexyl phthalate (mEOHP) | 14.0 | 17.4 | 16.2 | 16.3 | |
Di-isobutyl phthalate (DiBP) | Mono-isobutyl phthalate (miBP) | 6.0 | 8.7 | 7.0 | 8.2 |
Phenols | |||||
bisphenol A (BPA) | 1.6 | 2.1 | 1.6 | 1.9 | |